Acadia Pharmaceuticals Inc. (DR6)
Market Closed
17 Jul, 20:00
XFRA 
€
22. 02
-0.42
-1.8717%
€
- Market Cap
- P/E Ratio
- Div Yield
20 Volume
-0.34 Eps
€ 22.44
Previous Close Want to track DR6 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | 0.08 | - |
| | | 0.14 | - |
| | | 0.15 | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
DR6 Earnings Reports FAQ
What is the earnings per share (EPS) for DR6?
The current EPS is -0.34.
What is the company's earnings growth rate?
Acadia Pharmaceuticals Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Acadia Pharmaceuticals Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Acadia Pharmaceuticals Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for DR6 at this time, as Acadia Pharmaceuticals Inc has no recent EPS data to calculate it.
